Comparison of urinary proteins in calcium stone formers and healthy individuals: A case-control study

Urologia Internationalis

Volumn 76, Issue 2, 2006, Pages 163-168

  Pourmand, Gholamreza ^a,d   Nasseh, Hamidreza ^a   Sarrafnejad, Abdolfattah ^b   Mojtahedi, Alireza ^b   Mehrsai, Abdolrasoul ^a   Alamdari, Darioush Hamidi ^c   Nourijelyani, Keramat ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Nour Pathobiology Institute   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Albumin; Bacteriuria; Calcium stone formation; Tamm Horsfall protein; Transferrin

Indexed keywords

ALBUMIN; TAMM HORSFALL GLYCOPROTEIN; TRANSFERRIN;

ADULT; ARTICLE; BACTERIURIA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STATISTICAL SIGNIFICANCE; STONE FORMATION; URINE LEVEL;

ADULT; CALCIUM OXALATE; CALCIUM PHOSPHATES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; URINARY CALCULI;

EID: 33745046126     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090882     Document Type: Article

References (39)

1. Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H: Demographic and geographic variability of kidney stones in the United States. Kidney Int 1994;46:893-899.
2. Uribarri J, Oh MS, Carroll HJ: The first kidney stone. Ann Intern Med 1989;111:1006-1009.
3. Sutherland JW, Parks JH, Coe FL: Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 1985;11:267-269.
4. Strauss AL, Coe FL, Parks JH: Formation of a single calcium stone of renal origin: clinical and laboratory characteristics of patients. Arch Intern Med 1982;142:504-507.
5. Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB: Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978;50:449-454.
6. Boyce WH: Organic matrix of human urinary concretions. Am J Med 1968;45:673-683.
7. Binette JP, Binette MB: The matrix of urinary tract stones: protein composition, antigenicity and ultrastructure. Scanning Microsc 1991;5:1029-1034.
8. Khan SR: Interactions between stone-forming calcific crystals and macromolecules. Urol Int 1997;59:59-71.
9. Ryall RL: Glycosaminoglycans, proteins, and stone formation: adult themes and child's play. Pediatr Nephrol 1996;10:656-666.
10. Worcester EM: Inhibitors of stone formation. Semin Nephrol 1996;16:474-486.
11. Ryall RL, Fleming DE, Grover PK, Chauvet M, Dean CJ, Marshall VR: The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Mol Urol 2000;4:391-402.
12. Lyons Ryall R, Fleming DE, Doyle IR, Evans NA, Dean CJ, Marshall VR: Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation. J Struct Biol 2001; 134:5-14.
13. Buchholz NP, Grover PK, Rutishauser G: Modern surgical treatment and basic research in urolithiasis: exclusive or complimentary? An overview. Arch Urol 1996;18:1-13.
14. Cao LC, Boeve ER, de Bruijn WC, Robertson WG, Schröder FH: A review of new concepts in renal stone research. Scanning Microsc 1993;7:1049-1064.
15. Doyle IR, Ryall RL, Marshall VR: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin Chem 1991;37:1589-1594.
16. Morse RM, Resnick MI: A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 1988;139:869-873.
17. Bichler KH, Kirchner C, Ideler V: Uromucoid excretion of normal individuals and stone formers. Br J Urol 1975;47:733-737.
18. Samuell CT: Uromucoid excretion in normal subjects, calcium stone formers and in patients with chronic renal failure. Urol Res 1979;7:5-12.
19. Thornley C, Dawnay A, Cattell WR: Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond) 1985;68:529-535.
20. Erwin DT, Kok DJ, Alam J, Vaughn J, Coker O, Carriere BT, Lindberg J, Husserl FE, Fuselier H Jr, Cole FE: Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton. Am J Kidney Dis 1994;24:893-900.
21. Glauser A, Hochreiter W, Jaeger P, Hess B: Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects. Nephrol Dial Transplant 2000;15:1580-1587.
22. Ganter K, Bongartz D, Hesse A: Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients. Urology 1999;53:492-523.
23. Bichler K, Mittermüller B, Strohmaier WL, Feil G, Eipper El: Excretion of Tamm-Horsfall protein in patients with uric acid stones. Urol Int 1999;62:87-92.
24. Romero MC, Nocera S, Nesse AB: Decreased Tamm-Horsfall protein in lithiasic patients. Clin Biochem 1997;30:63-67.
25. Tardivel S, Medetognon J, Randoux C, Kebede M, Drüeke T, Daudon M, Hennequin C, Lacour B: Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers. Urol Res 1999;27:243-249.
26. Pupek-Musialik D: Usefulness of determining beta-2-microglobulin in serum and urine in patients with metabolically active kidney calculi and healthy individuals (in Polish). Pol Tyg Lek 1993;48:464-466.
27. Siddiqui AA, Sultana T, Buchholz NP, Waqar MA, Talati J: Proteins in renal stones and urine of stone formers. Urol Res 1998;26:383-388.
28. Fraij BM: Separation and identification of urinary proteins and stone-matrix proteins by mini-slab sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Clin Chem 1989;35:658-662.
29. Chen WC, Lin HS, Chen HY, Shih CH, Li CW: Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acids. Mol Urol 2001;5:1-5.
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
31. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
32. Ausubel FM, Brent R, Moore D, Smith JA, Moore DD (eds): Short Protocols in Molecular Biology, ed 4. New York, Wiley, 1999.
33. Grover PK, Marshall VR, Ryall RL: Tamm-Horsfall mucoprotein reduces promotion of calcium oxalate crystal aggregation induced by urate in human urine in vitro. Clin Sci (Lond) 1994;87:137-142.
34. Scurr DS, Robertson WG: Modifiers of calcium oxalate crystallization found in urine. III. Studies on the role of Tamm-Horsfall mucoprotein and of ionic strength. J Urol 1986;136:505-507.
35. Ryall RL, Grover PK, Stapleton AM, Barrell DK, Tang Y, Moritz RL, Simpson RJ: The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci (Lond) 1995;89:533-541.
36. Boeve ER, Cao LC, De Bruijn WC, Robertson WG, Romijn JC, Schröder FH: Zeta potential distribution on calcium oxalate crystal and Tamm-Horsfall protein surface analyzed with Doppler electrophoretic light scattering. J Urol 1994;152(2 Pt 1):531-536.
37. Wolska-Duda I, Dulawa J, Kokot F: Urinary excretion of Tamm-Horsfall protein, albumin and beta-2 microglobulin in children with recurrent urinary tract infection (in Polish). Pol Merkuriusz Lek 2001;11:36-39.
38. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S: Tamm-Horsfall protein knockout mice are more prone to urinary tract infection. Kidney Int 2004;65:791-797.
39. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR: Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004;66:1159-1166.